Consistently, the N-terminal part of GLP-2 is reoriented relative to GLP-1
In February 2026, Novo Nordisk announced it will slash US list prices by up to 50% for Ozempic, Wegovy, and Rybelsus effective January 2027, bringing the list price to $675/month ( [74] )
Sweetness in the gut Studies in vitro and ex-vivo with isolated human primary cells suggest that there are two temporally distinct pathways that lead to the glucose-stimulated release of GLP-1, similarly to what happens in -cells with the 1st or 2nd phase insulin release
What we can guarantee is a patient-centered approach
The company is looking at a loss of exclusivity for Humira after 20 years due to the release of Amjevita by Amgen, a biosimilar
Communication with Your Doctor : Maintain open communication with your doctor about any new or worsening symptoms, especially if you have a history of gastrointestinal issues